NCT02997046View on ClinicalTrials.gov

Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 12, 2016

Primary Completion Date

September 1, 2018

Study Completion Date

September 1, 2018

Conditions
Ferric CompoundsMagnetic Resonance AngiographyVascular GraftingArteriovenous FistulaKidney Transplantation
Trial Locations (1)

G12 8TA

NHS Greater Glasgow and Clyde, Glasgow

All Listed Sponsors
collaborator

NHS Greater Glasgow and Clyde

OTHER

lead

Sokratis Stoumpos

OTHER

NCT02997046 - Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter